New hope for restless leg sufferers: drug may ease treatment side effects
NCT ID NCT03218969
First seen Apr 27, 2026 · Last updated May 14, 2026 · Updated 4 times
Summary
This early-stage study tested whether ecopipam can reduce symptoms in people whose restless leg syndrome got worse from standard dopamine drugs. Ten adults took ecopipam or a placebo for six weeks, then switched. The goal was to see if the drug could ease leg discomfort and sleep problems without causing new issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESTLESS LEGS SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.